NCT04189952 Acalabrutinib in Combination With R-ICE For Relapsed or Refractory Lymphoma Status TERMINATED Phase PHASE2
NCT04187508 A Study to Evaluate the Effect of AZD8154 Administered Via Nebulizer Once Daily in Subjects With Mild Allergic Asthma Challenged With an Inhaled Allergen Status WITHDRAWN Phase PHASE2
NCT04187456 A Study in Healthy Male Subjects to Understand How Savolitinib When Taken With Midazolam Behaves Inside the Body Status COMPLETED Phase PHASE1
NCT04185012 NAsal Polyps: Inflammatory & Molecular Phenotyping of Responders to Benralizumab Status COMPLETED Phase PHASE3
NCT04184284 Change in Patient-Reported Outcomes in Severe Eosinophilic Asthma Patients Treated With Benralizumab Under Real-life Conditions Status COMPLETED Phase N/A
NCT04182802 MRI and Lung Function Measures of Benralizumab Response in Asthma Status WITHDRAWN Phase N/A
NCT04179071 A Study in Healthy Male Subjects to Understand How Savolitinib Behaves Inside the Body (Pharmacokinetics) When Administered Alone and in Combination With Famotidine Status COMPLETED Phase PHASE1
NCT04176848 CFI-400945 and Durvalumab in Patients With Advanced Triple Negative Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04169841 Study Evaluating the Efficacy of a Double Immunotherapy Combined With Olaparib in Patients With Solid Cancers and Carriers of Homologous Recombination Repair Genes After Olaparib Treatment Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04169737 Acalabrutinib and Venetoclax With or Without Early Obinutuzumab for the Treatment of High Risk, Recurrent, or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Status RECRUITING Phase PHASE2
NCT04168216 Study of Relationship Between Changes in Inflammation, Lung Function, Symptoms and Medication Use in COPD Patients Status COMPLETED Phase N/A
NCT04163432 Staggered, Chemo-Immunotherapy With Durvalumab, MEDI4736 Pemetrexed & Carboplatin (PC) for Metastatic Non-Squamous NSCLC Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04159519 A Study to Assess the Reduction of Daily Maintenance ICS/LABA Treatment Towards Anti-Inflammatory Reliever Treatment in Patients With Severe Eosinophilic Asthma Treated With Benralizumab Status COMPLETED Phase PHASE4
NCT04157348 Efficacy and Safety of Benralizumab in EGPA Compared to Mepolizumab. Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04157335 Efficacy and Safety Study of Benralizumab in Patient With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps (ORCHID) Status TERMINATED Phase PHASE3
NCT04156087 Progression-free Survival After MWA Plus Durvalumab and Tremelimumab for Unresectable Locally Advanced Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT04155645 To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD8233 After Multiple Dose Administration in Subjects With Dyslipidemia Status COMPLETED Phase PHASE1
NCT04152941 Real-life Data of Olaparib in Relapsed Ovarian Cancers Patients Status COMPLETED Phase N/A